---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-25-000003"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-28T00:41:18.680116+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific reaches preliminary settlement of derivative lawsuits over LOTUS Edge recall

## Summary
- On January 8, 2025, a U.S. district court granted preliminary approval of a settlement of two shareholder derivative actions related to the LOTUS Edge recall.
- The proposed settlement, dated September 6, 2024, includes corporate governance reforms such as amendments to committee charters and insider trading policy.
- A final approval hearing is scheduled for March 25, 2025 at 2:00 p.m. Eastern Time.
- The derivative lawsuits alleged breaches of fiduciary duty and violations related to the prior recall and retirement of the LOTUS Edge Aortic Valve System.
- Under the settlement, Boston Scientific will adopt governance reforms to remain in effect for at least three years.

## SEC filing metadata
- accession: 0000885725-25-000003
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572525000003/0000885725-25-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572525000003/bsx-20250116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-25-000003
- JSON: https://secwatch.observer/filing/0000885725-25-000003.json
- Plain text: https://secwatch.observer/filing/0000885725-25-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.